[2] Your doctor needs to know your recent hemoglobin A1c, typical glucose readings, and whether you have experienced any recent hypoglycemic episodes
Kidney Disease Patients with acute or worsening kidney disease are advised against Semaglutide
Regular monitoring of weight, blood pressure, and relevant laboratory parameters (such as hemoglobin A1c in diabetic patients) provides objective feedback on treatment response
Its mechanism of action includes stimulating insulin secretion in a glucose-dependent manner, suppressing glucagon release, slowing gastric emptying, and reducing appetite through central nervous system pathways
Baseline characteristics significantly impact early results
The gradual titration schedule is evidence-based and designed to optimize both efficacy and tolerability over the full treatment course